Comparative Effectiveness and Safety of High ‐Dose Rivaroxaban and Apixaban for Atrial Fibrillation: A Propensity Score‐Matched Cohort Study
ConclusionIn this study, composite effectiveness and safety varied between rivaroxaban and apixaban. High ‐dose apixaban was observed to have better effectiveness and safety in patients with AF.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Sylvie Perreault,
Alice Dragomir,
Robert C ôté,
Aurélie Lenglet,
Brian White‐Guay,
Simon de Denus,
Mireille E Schnitzer,
Marie‐Pierre Dubé,
James M Brophy,
Marc Dorais,
Jean‐Claude Tardif Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
More News: Atrial Fibrillation | Bleeding | Databases & Libraries | Drugs & Pharmacology | Gastroenterology | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Stroke | Study
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024